Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of Prolarix in hepatocellular carcinoma
2008-000912-34Phase 2Completed
- Sponsor
- Protherics PLC
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of caricotamide in hepatocellular carcinoma (HCC), sponsored by Protherics PLC. Primary endpoint: Overall tumour response rate. Started Apr 2008; status: completed.
02
Drugs
caricotamide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2008-000912-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000912-34.